Head-to-head · The Match Score
CoreAge Rx vs LVNG RX
Both scored on the same six-factor Match Score. CoreAge Rx wins this matchup with a 91 to 56 edge.
CoreAge Rx
#1 · Grade A−
Anyone who wants transparent flat pricing, fast nationwide access, and no teaser-rate bait-and-switch.
Visit CoreAge RxLVNG RX
#361 · Grade C
People who want cash-pay shoppers drawn to a low semaglutide from-price who will confirm the real plan cost before paying.
Visit LVNG RXFactor by factor
The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.
Price, coverage & formulary
| Detail | CoreAge Rx | LVNG RX |
|---|---|---|
| Semaglutide | $149/mo | $149/mo (starting dose, compounded) |
| Tirzepatide | $349/mo | $249/mo (microdose tier, starting dose, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injectable only | Injectable only |
| Match Score | 91 · A− | 56 · C |
CoreAge Rx is our #1-ranked provider overall, and it takes this matchup too — a 91 Match Score to LVNG RX's 56. The best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.
LVNG RX is still a fair pick if its strengths line up with yours — best for: People who want cash-pay shoppers drawn to a low semaglutide from-price who will confirm the real plan cost before paying.
Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.
More head-to-heads
- CoreAge Rx vs Strut Health
- CoreAge Rx vs HealthRX
- CoreAge Rx vs ShedRx
- CoreAge Rx vs Ondra Health
- CoreAge Rx vs Enhance MD
- CoreAge Rx vs Eden
Or browse alternatives to CoreAge Rx and all comparisons.
Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.